---
schema_version: "secwatch.filing_event.v1"
accession: "0001522767-26-000070"
form_type: "8-K"
ticker: "MRMD"
cik: "0001522767"
company_name: "MARIMED INC."
filed_at: "2026-05-13T21:13:09+00:00"
generated_at: "2026-05-13T21:14:44.090937+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# MariMed Q1 revenue $39.5M (+4.2% YoY); net loss narrows to $3.8M; adj. EBITDA $3.6M

## Summary
- Revenue $39.5M, up 4.2% YoY from $37.9M.
- GAAP net loss $3.8M, improved from $5.5M loss in prior year.
- Non-GAAP net loss $3.2M, improved from $3.9M.
- Adjusted EBITDA $3.6M (9% margin) vs $2.5M (7% margin) YoY.
- Gross margin slightly declined: GAAP 39% (vs 40%), Non-GAAP 40% (vs 41%).

## SEC filing metadata
- accession: 0001522767-26-000070
- form_type: 8-K
- ticker: MRMD
- cik: 0001522767
- company_name: MARIMED INC.
- filed_at: 2026-05-13T21:13:09+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000070/0001522767-26-000070-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000070/mrmd-20260513.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001522767-26-000070
- JSON: https://secwatch.observer/filing/0001522767-26-000070.json
- Plain text: https://secwatch.observer/filing/0001522767-26-000070.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.